Podcasts about pharmaceutical

Can depression be healed without antidepressants? Josh Trent welcomes Pixie Acia, Spiritual Wellness Coach, to the Wellness + Wisdom Podcast, episode 771, to share how nutraceuticals helped her transition off 15 years of antidepressants, why trauma shows up in our bodies until we face it, and how breathwork, community, and cycle-breaking practices can unlock healing far beyond pharmaceuticals. Nutraceuticals from Altrient (LivOn Labs) In order to repair the structural damage caused by a continual barrage of toxic substances and pathogens, your body requires a constant supply of phospholipids. Whilst humans can synthesise some phospholipid compounds, others are sourced from food. Phospholipids that are obtained from the diet are called ‘essential phospholipids'. The liposomes used in Altrient products are made from essential phospholipids that include a high percentage of Phosphatidylcholine (PC). These liposomes not only provide optimum protection and transport, but they also satisfy the body's need for PC, omega-6 fatty acids, and choline. Now Altrient has taken the power of LET out of the laboratory and put it into your hands. It's why Altrient products are so effective. High-performance nutrients delivering enhanced absorption! Try it for yourself In This Episode, Pixie Acia Uncovers: [01:10] Nutraceuticals: Natural + More Efficient than Anti-Depressants The role of nutraceuticals in treating depression. Why Pixie spent 15 years on depression medications. How liposomal applications help us absorb 80-90% of nutrients from a supplement. Why nutraceuticals provide clarity and allow us to feel our emotions more than antidepressants. How nutraceuticals affect both the brain and the gut. Why depression is a combination of trauma and imbalances in the brain. We can't heal from depression with just one practice. Resources: Pixie Acia LivOn Labs (Altrient) [07:30] Does a Vegan Diet Cause More Harm than Good? How a vegan diet ruined Pixie's health. Why she attached her identity to being vegan and stopped listening to her body. How she switched to a carnivore diet to feel better. Resources: The Effects of Vegan Diet on Fetus and Maternal Health [12:50] The Gift in Traumatic Experiences Why we care about what other people think about us based on evolution. How trauma took Pixie's innocence and childhood. Why tattooing her body was a trauma response. How she channelled her trauma to help others. Why Pixie learned to detach from her body when she was abused. How forgiveness can help us let go. [19:10] Healed People Heal People How healed people heal other people. Why Pixie believes she went through her trauma for a reason. How her traumatic experience has helped her help others move through their trauma. [22:30] The Healing Power of Breathwork How breathwork helps us connect with our body. Why breathwork allowed Pixie to free herself from her traumatic sexual past. How breathwork can open us to new dimensions. Why we can get downloads from breathwork sessions. What led her to change her name from Amber to Pixie. [29:30] Why Do You Chase Dopamine? How the body is always looking for safety. Why Pixie attracted the same type of men until she healed her wounds. How chasing dopamine is a trauma response. Why Pixie created challenges to keep people accountable for their growth and getting healthy dopamine. It takes 62 days to create a new habit. [37:10] Becoming A Cycle Breaker Why Pixie found it hard to dance because of her sexual trauma. How expressing her sexuality made her feel like she would be taken advantage of. What pushed her to break the cycle. Resources: Michael Edward Johnson's Latch Theory The Body Keeps The Score by Bessel van der Kolk [43:50] The Value of Community Why community is the new currency. How human connection will become more valuable. What it means to be a safe container for others. How people come up against their projections and beliefs when they go to a retreat. Why when you let people see us, we become more lovable. [49:35] The Catalyst for Change What happened and why it happened doesn't truly matter. Why what we don't express shows up as depression or disease. How doing our own healing helps other people heal. Leave Wellness + Wisdom a Review on Apple Podcasts All Resources From This Episode Pixie Acia LivOn Labs (Altrient) The Effects of Vegan Diet on Fetus and Maternal Health Michael Edward Johnson's Latch Theory The Body Keeps The Score by Bessel van der Kolk Power Quotes From Pixie Acia "What is repressed will eventually get expressed as depression or disease." — Pixie Acia "If you suffer from depression, you need nutraceuticals. They help not just build the foundational blocks in the brain, but also in the gut, affecting the serotonin and giving you the essential support that it needs to not be depressed." — Pixie Acia "Your nervous system is looking for familiar situations to identify whether it's safe or not. When we're used to repressing it, we aren't listening to the body to know if we're safe or not. And then we'll end up finding ourselves in similar situations again." — Pixie Acia  

Equity investment analyst Melissa Gallagher looks at why pharmaceuticals remain an attractive investment area and how obesity treatment and AI continue to drive innovation in this space.#CapGroupGlobal For our latest insights, practice management ideas and more, subscribe to Capital Ideas at getcapitalideas.com. If you're based outside of the U.S., visit capitalgroup.com for Capital Group insights.  Watch our latest podcast, Conversations with Mike Gitlin, on YouTube: https://bit.ly/CG-Gitlin-playlist  This content is published by Capital Client Group, Inc.   U.K. investors can view a glossary of technical terms here: https://bit.ly/49rdcFq  To stay informed, follow us  LinkedIn: https://www.linkedin.com/company/capital-group/posts/?feedView=all YouTube: https://www.youtube.com/@CapitalGroup/videos Follow Mike Gitlin: https://www.linkedin.com/in/mikegitlin/  About Capital Group  Capital Group was established in 1931 in Los Angeles, California, with the mission to improve people's lives through successful investing. With our clients at the core of everything we do, we offer carefully researched products and services to help them achieve their financial goals.  Learn more: capitalgroup.com  Join us: capitalgroup.com/about-us/careers.html  Copyright ©2025 Capital Group 

Chris Magee, Head of Policy and Media for the UK advocacy group Understanding Animal Research, and Naomi Charalambakis, Director of Science Policy & Communications at the US based advocacy group Americans for Medical Progress, joins me to discuss new directives from the US FDA and the EU regarding lab animal use. Join us to cover the realities of lab animal use today, as well as the history or public misinformation dating back before Charles Darwin!

In this episode, we take a critical look at the state of America's pharmaceutical supply chain with John Knox, the principal deputy Assistant Secretary for Preparedness and Responses at the Health and Human Services Department. Explore the recent innovations and executive orders aimed at revitalizing domestic drug manufacturing, including the potential for small-scale production of generic drugs. Next, we delve into the critical state of America's pharmaceutical industry with retired army colonel Vic Suarez, founder of Blue Zone Bioscience and Supply Chain Solutions. Vic shares his insights on the alarming dependency on foreign nations for essential medications and the urgent need for reform. Join us as we discuss innovative manufacturing technologies, the intersection of critical minerals and pharmaceuticals, and the future of on-demand medicine. Finally, we sit down with Congressman Rich McCormick, a Marine Corps veteran and doctor, to discuss crucial issues surrounding America's healthcare and defense systems. We delve into the implications of the pandemic on drug supply chains, the importance of domestic manufacturing, and the challenges faced in military procurement. Congressman McCormick shares insights on the Biden administration's handling of healthcare, the need for strategic independence, and the future of military supply systems. See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

As one of 2 countries with direct-to-consumer pharmaceutical ads, is it time to reel it in? Hour 3 9/15/2025 full 2020 Mon, 15 Sep 2025 21:00:00 +0000 wCsJG7P28rQxTvK3j7ekYItGScjqCZ7l news The Dana & Parks Podcast news As one of 2 countries with direct-to-consumer pharmaceutical ads, is it time to reel it in? Hour 3 9/15/2025 You wanted it... Now here it is! Listen to each hour of the Dana & Parks Show whenever and wherever you want! © 2025 Audacy, Inc. News False

Robert Abel, chief scientific officer at Schrödinger, says advanced computational tools are changing the pace and accuracy of drug discovery. In a recent episode of The Top Line podcast, Abel outlined three areas where AI and machine learning are making the greatest impact: understanding disease biology, predicting protein structures and designing drug molecules. Schrödinger’s platform uses physics-based simulations alongside AI to evaluate millions of molecules in days, compared with the thousands traditionally synthesized in a year. Abel pointed to real-world results, including a program that reached a clinical trial candidate in just 10 months — far faster than industry averages. He said the technology also helps overcome challenges such as improving drug selectivity and reducing the need for animal testing, aligning with FDA priorities. Abel will share more insights during his upcoming talk at AAPS PharmSci 360 in San Antonio this November. His session abstract is available here. To hear more about Schrödinger’s work in computational drug discovery, listen to the full interview.See omnystudio.com/listener for privacy information.

Liberated Life Series | Episode 770 Join Josh Trent, host of the Wellness + Wisdom Podcast, as he reveals why he went from complete astrology skeptic to believer after one session with world-class Astrologer Debra Silverman. Debra's framework exposed the exact patterns sabotaging his love and business life for years, patterns that over half a million people have now discovered. If you've been dismissing astrology as "woo-woo," this episode will show you the science-backed framework that reads your soul like a map and reveals the blind spots that are quietly running your life.

In this inspiring episode we feature Paige Speers. After surviving pulmonary blood clots and oxygen deprivation, Paige shares her holistic recovery path, integrating functional medicine, nutrition, chiropractic care and movement therapy. Discover how she navigated complex health challenges, including the surprising impact of long-term medication and found integrative resources to complement conventional treatment. This episode is a must-listen for anyone interested in brain injury recovery, natural anxiety solutions, holistic health and self-healing journeys.Learn about Paige's "Choosing Greater Health Community" and her mission to connect survivors with vital integrative and functional health practitioners. Tune in for practical tips and empowering insights on healing your body and mind.Key Points 00:00 Introduction 01:41 Meds, birth control and blood clots.07:11 Integrative health protocols.09:10 Therapeutic Horse riding and chiropractic aid healing.12:11 Built health community13:57 Tip for healing brain injuryPaige's Bio After surviving pulmonary blood clots and oxygen deprivation brain injury at 32, Paige channelled her innate resilience into recovery, finding whole person focused therapies centred around bringing all systems into balance in a way that would fill in the pieces and complement standard medicine. This brought in Paige's entrepreneurial vision of connecting other under-supported brain injury survivors with integrative and functional resources and practitioners, providing options to choose in alignment with their highest potentials. Additionally speaking and writing about her recovery path have been a focus.Connect with Paigewww.paigespeers.com Facebook profile https://www.facebook.com/paige.stratemeyerFacebook Group: https://www.facebook.com/share/FjBUye8j8y2Qz28N/?mibextid=K35XfPLinkedIn: https://www.linkedin.com/in/paige-speers-a9a38b62 Who am I?Sarah is a highly sought-after Holistic Health and Healing Coach, International Speaker and the Author of HEAL YOURSELF.She's also a Multi-Award-Winning Entrepreneur and Award Winning Host of the popular health-focused podcast, Heal Yourself with Sarah Dawkins. As a former Registered Nurse with over twenty years of medical experience, Sarah brings a unique, integrative perspective to her work. Sarah's expertise spans from self-healing multiple chronic health issues to supporting clients in uncovering and addressing the root causes of their symptoms, empowering them to achieve vibrant, lasting health and transformative wellness.www-sarahdawkins.com#BrainInjuryRecovery #BrainHealth #TBI #NeuroRecovery #BrainInjuryAwareness #CognitiveHealth #Neurofeedback #FunctionalMedicine #NaturopathicMedicine #ChiropracticCare #NutritionTherapy #MovementIsMedicine

Sales legend and trainer Steve Gielda—co-founder of Ignite Selling—joins Samuel to break down what truly drives performance in medical device, pharma, biotech, and diagnostics. Steve traces his path from selling 3M copiers out of a van to leading life-sciences consulting with Neil Rackham (of SPIN Selling) and building Ignite's simulation-based, gamified training that accelerates pipelines and product launches. We get tactical fast: how today's top reps think strategically, map real stakeholders (beyond the “friendly” contacts), and use smarter questions that challenge clinical and business assumptions—not just needs. Steve explains when SPIN still shines, where Challenger-style questions raise the bar, and why role-playing strategy is as critical as role-playing the call. For frontline managers, Steve lays out the playbook: coach early in the pipeline, ask more than you tell, know when to sell vs. when to coach, and—yes—let your reps fail on safe calls so they learn to win without you. We dive into work ethic vs. knowledge, turning average reps into top performers, and the signals that a high producer is (or isn't) ready for leadership. If you want practical frameworks to sharpen your questioning, focus your account strategy, and elevate your team's coaching culture, this episode delivers candid insights you can apply on your very next call. Connect with Steve: LinkedIn Connect with Me: LinkedIn Love the show? Subscribe, rate, review, and share! Here's How » Want to connect with past guests and access exclusive Q&As? Join our EYS Skool Community today!

Liberated Life Series | Episode 768 Join Josh Trent, host of the Wellness + Wisdom Podcast, as he reveals why ignoring the Hermetic principles traps you in repeating patterns, and how understanding them unlocks your true power. The Hermetic Laws are like the universe's mirror. If you don't understand them, life will reflect back your inner chaos, but if you do, they unlock your highest potential.

01:00:44 – RFK Jr. Torches Senate RFK Jr. clashes with senators, calling Maggie Hassan a liar and exposing CDC corruption. He slams pharma influence and cites data showing suppressed autism risks. 01:07:55 – Autism Cover-Up Exposed RFK Jr. details a 2002 CDC study showing black boys had a 260% higher autism risk with early MMR shots—data destroyed by officials to protect pharma. 01:11:10 – Cassidy Traps RFK Jr. Sen. Bill Cassidy forces RFK Jr. to endorse Trump's Operation Warp Speed, calling it Nobel-worthy. RFK caves, exposing his compromise with Trump's ego. 01:16:10 – Senators Bought by Pharma Discussion lists senators pocketing millions from vaccine makers: Warren, Sanders, Romney, Cassidy, and others. Both parties are shown as fully captured by pharma. 01:23:16 – Spike Protein = Bioweapon Listener analysis ties vaccine harms to spike protein's destruction of ACE2, fueling myocarditis, clotting, and turbo cancers. Critics call the jabs a Pentagon-DARPA bioweapon. 01:27:33 – Trump, Gates, and Zuckerberg Dinner Trump dines with Bill Gates and Mark Zuckerberg at the White House. Commentary frames it as proof Trump embraces technocrats pushing AI, depopulation, and new mRNA delivery systems. 01:51:24 – Tim Kaine: Rights From Government Sen. Tim Kaine claims rights come from government, not God—sparking outrage. Ted Cruz rebukes him with Jefferson's words, while critics tie Kaine's stance to Marxist liberation theology. 01:59:42 – Liberation Theology = KGB Ops Discussion traces Kaine's worldview to “liberation theology,” described as a KGB psyop to destabilize the West. Parallels are drawn to Pope Francis and modern Marxist infiltration in religion. 02:03:47 – DOJ Pushes Gun Ban for Transgender People DOJ considers labeling transgender individuals as mentally ill to strip gun rights. Critics warn it's a Trojan horse for red flag gun laws and Trump-style “due process later” policies. 02:07:47 – Trans Militancy & Socialist Rifle Association Zero Hedge report links trans shooters with the far-left Socialist Rifle Association, whose rainbow-AR-15 imagery echoes recent killings. Hosts warn conservatives are being baited into cheering gun control. 02:17:13 – Trump's Asylum Agenda Trump and Melania push reopening mental institutions and mandatory mental health screenings. Critics warn this echoes totalitarian regimes weaponizing psychiatry to silence dissent. 02:19:54 – John Rich vs. TVA Land Grab Country singer John Rich helps Tennessee locals fight the TVA's eminent domain scheme for a methane gas plant. After massive pushback, TVA cancels plans—framed as a rare grassroots victory against corporate-government overreach. 03:05:52 – Gold Soars on Weak Jobs Gerald Celente joins to discuss gold hitting $3,600 amid dismal job numbers. Weak labor markets signal looming rate cuts, sinking the dollar and driving investors to safe havens. 03:09:12 – Trump's Crypto Empire Exposed Discussion shifts to how Trump's family quietly moved massive wealth into Bitcoin and crypto mining. His stake is now larger than his global resorts, raising conflict-of-interest concerns. 03:12:54 – Dragflation & Debt Heart Attack Celente predicts “dragflation”—declining growth plus surging inflation—as debt tops $220 trillion. Ray Dalio's warning of a “debt-induced heart attack” within three years is echoed as inevitable. 03:14:42 – Gold Goes Digital The World Gold Council prepares to tokenize bullion for global trading. Analysts warn it could wipe out unstable cryptocurrencies and challenge U.S. dollar dominance. 03:26:02 – H-1B Scam & Cheap Labor Conversation turns to H-1B visas, tracing back to Bill Clinton and expanded under Trump and Biden. Both parties are accused of flooding the U.S. with cheap foreign labor to suppress wages. 03:36:02 – Venezuela Strike = Oil Grab Trump's shoot-first policy in Venezuela is blasted as a false “drug war” pretext to seize oil. Comparisons are drawn to Duterte's Philippines and past regime-change coups. Follow the show on Kick and watch live every weekday 9:00am EST – 12:00pm EST https://kick.com/davidknightshow Money should have intrinsic value AND transactional privacy: Go to https://davidknight.gold/ for great deals on physical gold/silverFor 10% off Gerald Celente's prescient Trends Journal, go to https://trendsjournal.com/ and enter the code KNIGHTFind out more about the show and where you can watch it at TheDavidKnightShow.com If you would like to support the show and our family please consider subscribing monthly here: SubscribeStar https://www.subscribestar.com/the-david-knight-showOr you can send a donation throughMail: David Knight POB 994 Kodak, TN 37764Zelle: @DavidKnightShow@protonmail.comCash App at: $davidknightshowBTC to: bc1qkuec29hkuye4xse9unh7nptvu3y9qmv24vanh7Become a supporter of this podcast: https://www.spreaker.com/podcast/the-david-knight-show--2653468/support.

Liz Warren is calling for RFK Jr. to resign as Secretary of Health & Human Services. He's right, though. She took over $800,000 dollars of PAC money on behalf of Pharmaceutical companies.

"Sustainability isn't just about doing the right thing. It's about making smarter, more cost effective decisions that are really building stronger, more reliable supply chains."Christiane Walker, Product Development Team Lead at Intelsius, believes the pharmaceutical industry stands at a critical juncture where environmental responsibility and operational excellence must converge.Christiane Walker leads the product development team at Intelsius, managing cross-functional teams that design innovative and sustainable packaging solutions. With four years at the company, she brings deep expertise in temperature-controlled transport packaging, working with pharmaceutical clients across global markets to optimise their cold chain operations.In the latest PharmaSource podcast episode, Christiane explains how pharmaceutical companies can simultaneously reduce their carbon footprint, cut operational costs, and improve supply chain resilience through strategic adoption of sustainable packaging technologies and connected digital systems.

In this special edition, we take you inside the Infection Control African Network Congress 2025, held in beautiful Cape Town from 29 June to 2 July. Vin was on the ground capturing the energy, innovation, and passion driving infection prevention and control (IPC) across Africa and beyond. From cutting edge updates in infection control programs to inspiring discussions on IPC education, this episode is packed with insights straight from the experts. And for an extra twist, three conference attendees stepped up as momentary messengers for the day, bringing fresh perspectives as they interviewed some of the most fascinating voices at the congress.Our adhoc hosts:Dr Lesego MothibiDr Gilda MadeiraDr Julia PhambaneAbout our Guests: Dr Amanda Khumalo FCPath, DTM&H, Clinical Microbiologist PathCare Laboratories, see bio HERE: The role of the HCW in breaking the chain of infectionDr Ifeyinwa Nwafia, Clinical Microbiologist, Management Sciences for Health, Nigeria : Assessment of the Pattern of Antimicrobial Use Among Hospitalized Patients in 16 Nigerian Hospitals: a Strategy to Improve Antimicrobial Stewardship ProgrammeMr David Frederick, Pharmaceutical technologist, Malindi Sub-County Hospital, Kenya, Best Poster Winner ICAN25: Building a foundationMrs Briette du Toit Ludick, PG Infection Prevention and Control, MSc IPC: Cost effectiveness of implementing an environmental Cleaning programmeTawanda Mutiwazuka, Medical Virologist, The Avenues Clinic, Zimbabwe, Reflecting on the ICAN25 congress. WE'D LOVE YOUR FEEDBACK ON THIS EPISODE – Visit the Microbe Mail website to sign up for updates Follow on:Instagram: Microbe_MailX/Twitter: @microbemailFacebook: MicrobeMailTiktok: @microbe.mailWatch this episode on our new YouTube channel: Microbe MailE-mail us: mail.microbe@gmail.com

Drug pricing in America is a shell game where patients always lose. Healthcare Bridge host Nathan Kaufman and his guest Richard Helppie pull back the curtain on why Americans pay drastically more for the same medications than patients anywhere else in the world.At the heart of this problem lies a fragmented system where the United States—effectively operating the world's largest health insurance company—somehow lacks the ability to negotiate bulk purchasing deals. While pharmaceutical companies claim high prices fund critical research, the conversation reveals how your money primarily finances the endless parade of drug advertisements dominating television commercial breaks.The journey of a pill from factory to patient passes through multiple profit-extracting entities: manufacturers, wholesalers, and pharmacy benefit managers (PBMs). With three PBMs controlling 80% of drug distribution—all owned by insurance companies—conflicts of interest are baked into the system. Through revealing personal anecdotes, the hosts demonstrate how the same medication can cost $5 with one insurer, $330 with another, yet only $20 through Mark Cuban's pharmacy. Many Americans find it cheaper to purchase medications from Canadian pharmacies despite industry warnings about "dangerous" reimported drugs—even when those medications come from identical manufacturing facilities.Recent policy proposals offer potential paths forward. The Biden administration's efforts to cap Medicare drug expenses met immediate legal challenges from pharmaceutical companies, while Trump's "most favored nation" pricing concept aims to standardize global medication costs. Medicare Part D represents a partial success story by forcing drug companies to negotiate with insurers, maintaining 95% subscriber satisfaction while running 40% below projected costs.Healthcare policy requires informed leadership, but few politicians truly understand the system's complexities. If you or someone you love needs medical care, finding an insider who understands healthcare's nuances isn't just helpful—it could save your life. Subscribe to the Healthcare Bridge for more conversations that bridge gaps in our healthcare system and work toward solutions that benefit patients first.Support the showEngage the conversation on Substack at The Common Bridge!

War Room It's Happening! Trump Calls on Pharmaceutical Companies to “Justify Success” of Covid-19 “Vaccines”

Listen in as our expert panel discusses the latest recommendations for managing medications after heart attacks and other cardiac events. You'll hear our panelists review which antiplatelets to use, the optimal blood pressure meds, and the role of statin and non-statin cholesterol meds.Special guests:Danielle Blais, PharmD, FCCP, BCCP, BCPSCardiology Lead Specialty Practice PharmacistRichard M. Ross Heart HospitalThe Ohio State University Wexner Medical CenterJoel C. Marrs, PharmD, MPH., BCACP, BCCP, BCPS, FAHA, FASHP, FCCP, FNLAProfessor and Coordinator of Clinical OutreachThe University of Tennessee Health Science CenterDepartment of Clinical Pharmacy & Translational ScienceYou'll also hear practical advice from panelists on TRC's Editorial Advisory Board:Andrea Darby-Stewart, MDAssociate Director, Honor Health Family Medicine Residency ProgramClinical Professor of Family, Community & Occupational MedicineThe University of Arizona College of Medicine – PhoenixCraig D. Williams, PharmD, FNLA, BCPSClinical Professor of Pharmacy PracticeOregon Health and Science UniversityNone of the speakers have anything to disclose. This podcast is an excerpt from one of TRC's monthly live CE webinars, the full webinar originally aired in July 2025.TRC Healthcare offers CE credit for this podcast. Log in to your Pharmacist's Letter, Pharmacy Technician's Letter, or Prescriber Insights account and look for the title of this podcast in the list of available CE courses.Claim CreditThe clinical resources mentioned are part of a subscription to Pharmacist's Letter, Pharmacy Technician's Letter, and Prescriber Insights: Dual Antiplatelet Therapy for Coronary Artery DiseaseComparison of Oral Beta-BlockersAngiotensin Receptor Blockers and Angiotensin-Converting Enzyme InhibitorsCholesterol Guidelines (United States)Non-Statin Lipid-Lowering AgentsSend us a textIf you're not yet a subscriber, find out more about our product offerings at trchealthcare.com. Follow, rate, and review this show in your favorite podcast app. Find the show on YouTube by searching for ‘TRC Healthcare' or clicking here. You can also reach out to provide feedback or make suggestions by emailing us at ContactUs@trchealthcare.com.

Good morning from Pharma and Biotech daily: the podcast that gives you only what's important to hear in Pharma e Biotech world.Regeneron's experimental drug for myasthenia gravis, cemdisiran, has shown promising results in a Phase III trial and the company is aiming to file for FDA approval by 2026. Pharmaceutical spending in China has reached record levels, with more than $48 billion spent in the first half of the year. Former FDA Commissioner Scott Gottlieb has raised concerns about the US losing its edge in biopharma innovation to China. Additionally, a drug program for a rare neurodegenerative disorder has been discontinued by Amylyx, while pharma companies are increasingly focusing on scientific research and partnerships. Lilly's obesity pill is heading to the FDA for approval, AbbVie is investing in psychedelics, and HHS has announced more changes in the industry. The pharmaceutical landscape is rapidly evolving with new developments and challenges arising.Pharma CEOs are facing increasing pressure amid political turmoil and public distrust over drug pricing. The industry spent over $48 billion in China in the first half of the year, with expectations of increased deal volume in the future. Legal experts are working to determine ownership rights of AI creations in biotech. Obesity treatments are being compared for effectiveness, while biotech companies are making strides in AI-driven manufacturing. Job opportunities in gene therapy and biostatistics are available.

Rising drug costs, persistent shortages, and a maze of middlemen—how do we fix America's medicine market without losing innovation or access? In this episode, Justin Giboney sits down with Emily Lampkin of thePharmaceutical Reform Alliance to unpack practical, bipartisan pathways for pharmaceutical reform and what faithful civic engagement can look like for churches and communities. Learn more about your ad choices. Visit podcastchoices.com/adchoices

In this episode of The New Warehouse Podcast, Kevin chats with Joel Wayment, Vice President and General Manager of Third-Party Logistics (3PL) and Packaging Solutions at Cardinal Health. Joel shares how Cardinal Health supports pharmaceutical manufacturers by managing complex logistics and packaging requirements to ensure life-saving products reach patients in perfect condition. He also discusses sustainability, visibility technology, and network planning for pharmaceutical logistics. He emphasizes that every medical supply chain shipment affects not only the patient but also their family and loved ones.Find EPG at IntraLogistex Miami in September! Get better visibility with Surgere. Follow us on LinkedIn and YouTube.Support the show

NSC continue their slump and were defeated 3-0 in the Big Apple.  No need to panick just yet, NSC are still alive and playing for 3 trophies.  Thanks for listening! 

Pharmaceutical companies are among the most maligned companies in America. BIG PHARMA are the constant and consistent targets of lawyers, sarcastically termed “ambulance chasers.” One bad incident can result in lawsuits which may produce tens of millions of dollars in damages.But, every day, these companies produce and provide lifesaving, life-extending, life-transforming therapies to millions upon millions in the United States and, of course, around the world. I wonder how many people would die tomorrow without the drugs produced by BIG PHARMA which keep them alive.Some experts indicate that every single American citizen, old and young, has been the beneficiary of a drug, or takes one on a regular basis. I wonder, has your body been the recipient of a drug, or does it take on now sporadically or on a regular basis? Or, in a life-saving moment, have you been the very fortunate recipient of a life-saving drug produced by BIG PHARMA. Have you?No matter, the relentless assault on pharmaceutical companies goes on. Some of the criticism and cry for control by the government is justified, and most of it, NOT JUSTIFIED. There are federal agencies like the FDA, a governmental watch dog, presumably protecting the people, protecting WE THE PEOPLE, making certain that only safe and effective drugs reach the market. But, because of the vilification of BIG PHARMA, regulators at the federal level are often hesitant in granting permission for a drug to be marketed, no matter its lifesaving or life-extending capabilities. The constant delay, testing, examinations of all kinds, no matter how necessary, add significantly to the cost of the drug when you and I purchase it.In many cases, politicians do the most harm. Their incendiary rhetoric corrupts public understanding, and in some cases, stokes outright hatred. Governmental policies make it far easier for BIG PHARMA to be sued for the very slightest matter. Huge judgements occur, and the cost of the drug goes up, or even in some extreme cases, off the market entirely. When that happens, there comes the hue and cry from the public for price controls, firmer and stronger regulations against BIG PHARMA, and the relaxation of protections for pricing, and especially PATENTS, which protect the drugs against competition for any number of years. Then there arises the public climber for GENERIC DRUGS which WE THE PEOPLE believe will have the very same beneficial effects for a lower price.In the favor of BIG PHARMA, these often-incredible drugs are born out of some of the world's most INGENIOUS INNOVATION AND IMAGINATION. The minds, brilliant minds, of the scientists who make these drugs happen are rare commodities on this Earth. Months and years are devoted to research testing, trial and error, before a drug is presented to federal regulators for approval with the request for marketing to the needy patients of the world. The scientists in BIG PHARMA work for the cures of the most horrendous diseases (i.e. Alzheimer's) investing tens of millions of dollars in such research, with no guarantee that investment will be returned, much less make a profit. Politicians and lawyers are determined that they will NOT!When, my fellow Americans, was the last time you were given a drug which saved your life, extended it, or cured a condition, small or large, and without which, your life may have been ended or permanently riddled with pain? Do you take the products of BIG PHARMA, the drugs, any of them on a regular basis, to save your life, or improve the quality of that life, do you? And if you do, are you grateful, thankful, for the men and women who invested tens of thousands of hours and dollars to make that drug and make your life better? No operation of any kind can occur without drugs, none. Whether anesthesia, or some other, no operation would be safe or curative. Instead of chastising BIG PHARMA, perhaps WE THE PEOPLE, the blessed recipients of these drugs, should give thanks to them and hope and pray they continue their absolutely necessary work in research and development (R&D).Let us hope and pray BIG PHARMA continues to invest, recruit the most brilliant scientific minds, motivates the innovators to give their lives in the search for new medicines and cures for the benefit of all humankind, in America and worldwide. Imagine for one minute what America, the world, or even your life would be like if there were no drugs available. That includes the most expensive to the very simple Aspirin, drugs produced from years of costly investment on the one hand, and over the counter on the other.To be sure, on occasion, there is greed, overpricing, and some marketing unfairness which may exist. But, those circumstances are rare, infrequent, can easily be detected, and just recompense delivered. Innovation is incredibly expensive, as is real, creative research and testing, INCREDIBLY EXPENSIVE! If there is not fair payment for those services or a profitable return on investment, those innovative minds which provide us, WE THE PEOPLE, with the drugs that extend, save, or improve the quality of our lives, will spend their innovative lives in other industries. Even scripture tells us that no one builds a tower (develops a new drug) without considering the cost thereof and at the bottom line, that workman (BIG PHARMA and its innovative people) is entitled to the real value, the fair and profitable wage and return, on the products produced.So, my fellow Americans, what would your life be like if you had never had the benefit of a drug produced by BIG PHARMA? Would your life be the same, or would you even have life at this point in time? Governmental controls, pricing, and regulations would do nothing but destroy innovation, drive away the very best scientists, and allow the constant assault of diseases, old and new, to rule the day. Do not let that happen. We must, somehow, find the way to thank and encourage BIG PHARMA on the one hand, and on the other, provide these drugs to those who so desperately need them. I, for one, believe OUR GREAT PHYSICIAN would so have it, our Lord Himself, even more so than the innovators He has given us.

Send us a textThe U.S. economy is shifting fast — and three big moves out of Washington could change the way you borrow, shop, and even afford your prescriptions. In this episode, we connect the dots on what's happening and why it matters for your wallet:A shake-up at the Federal Reserve – President Trump appoints Stephen Miran, his own economic adviser, to the Fed Board. We break down what this means for interest rates, inflation, and your mortgage.Pharmaceutical tariffs up to 250% – Why your medications could cost more, how it could spark a domestic manufacturing push, and what that means for your health budget.Reciprocal tariffs in effect – Dozens of U.S. trading partners face new tariffs, raising prices on everything from avocados to electronics.You'll get the context behind each move, the ripple effects on the economy, and practical steps to prepare. Whether you're filling a prescription, refinancing a loan, or buying groceries, this episode is your early warning on the changes ahead.Links: New Federal Reserve 1New Federal Reserve 2New Federal Reserve 3Pharma Medication COULD be facing a 250% TariffTariffs Into EffectSupport the show

Kansas Senator Doc Marshall joins John Solomon and discusses President Trump's recent executive order aimed at enhancing the safety and security of our drug supply, the necessity of stockpiling ingredients, and the importance of bringing pharmaceutical manufacturing back to the United States. Additionally, we explore a significant legal victory in Colorado concerning abortion restrictions with Hal Frampton from the Alliance Defending Freedom. Finally, Dr. Peter McCullough discusses health issues and the benefits of a parasite cleanse. See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

Pharmaceutical companies are scrambling to respond to the Trump administration's tariff threats, seeking to mitigate duties on their products while keeping the impact on their tax bills to a minimum.   The industry has long leveraged complex transfer pricing arrangements to cut down on its tax bills, but now the looming tariffs could spark a major rethink for where companies make their drugs and the location of their crown jewel: the intellectual property. Pharmaceuticals were exempt from the initial wave of tariffs announced earlier this year, but subsequent months have seen threats of heavy fines and taxes from the administration and a looming national security investigation, which could result in heavy duties on the industry.   In this week's Talking Tax podcast, Cronus Consulting founder Nick Shipley talked with reporter Caleb Harshberger about how pharmaceutical companies are navigating the chaos, and what it could mean for their tax planning and operations. Shipley is a consultant for the pharmaceutical industry. Do you have feedback on this episode of Talking Tax? Give us a call and leave a voicemail at 703-341-3690.

In this episode of the ChinaPower Podcast, Dr. Yanzhong Huang joins us to examine China's growing influence over the global pharmaceutical industry and the risks it poses for the United States. Dr. Huang explains how China evolved from a low-cost manufacturer of chemical inputs to a comprehensive pharmaceutical power producing advanced drugs and playing an important role in global pharmaceutical innovation. He highlights areas of acute U.S. dependence, from antibiotics and vitamins to critical precursor chemicals, and recounts how the Covid-19 pandemic underscored the vulnerability of U.S. supply chains. Dr. Huang explains the highly interdependent nature of global drug supply chains and notes that even if countries attempt to build alternative production capacity outside of China, they would still rely on Chinese suppliers at certain stages of the supply chain and would need years to replicate China's integrated industrial ecosystems. He concludes with an assessment of U.S. policy options for building resilience, including targeted de-risking of key medicines and diversifying suppliers among trusted partners.  Dr. Yanzhong Huang is a senior fellow for global health at the Council on Foreign Relations, where he directs the Global Health Governance roundtable series. He is also a professor and director of global health studies at Seton Hall University's School of Diplomacy and International Relations, where he developed the first academic concentration among U.S. professional international affairs schools that explicitly addresses the security and foreign policy aspects of health issues. He is the founding editor of Global Health Governance: The Scholarly Journal for the New Health Security Paradigm.  Dr. Huang is the author of multiple books and reports, including most recently The COVID-19 Pandemic and China's Global Health Leadership, published in 2022. 

We have officially moved on from genetically modified plants, animals and fish to completely replacing them with lab-grown versions. From fake butter made with natural flavoring from Savor to the fake fish of Wildtype, we are told to eat meat alternatives to save the world by the same people told us to only eat plants to save the world. This list is expanded by fake chicken, and insect flour, ice cream, and milk. None of this should surprising either considering the cult of pharmaceutical drugs, surgeries, makeup, and how mothers are encouraged not to breastfeed their babies and instead feed them formulas and foods made by companies like Gerber, who are still in court over knowingly selling heavy-metal laced products. *The is the FREE archive, which includes advertisements. If you want an ad-free experience, you can subscribe below underneath the show description.FREE ARCHIVE (w. ads)SUBSCRIPTION ARCHIVEX / TWITTER FACEBOOKWEBSITECashApp: $rdgable EMAIL: rdgable@yahoo.com / TSTRadio@protonmail.comBecome a supporter of this podcast: https://www.spreaker.com/podcast/the-secret-teachings--5328407/support.

The White House has declared war on Latin American drug cartels. Although this seems like great news, has anyone stopped to ask if the goal is to shut down competition? Recent executive orders from May stripped regulations for domestic pharmaceutical production in the United States and attempted to create a direct-to-consumer purchasing program to subvert insurance companies. This is in a country that consumes more pharmaceutical drugs than any other on planet Earth. Likewise, the opioid crisis was created by the same industry. There are more bad actors than just the stereotypical south of the border drug cartels as we also learned with Iran-Contra. HHS secretary RFK Junior is furthermore being praised for cutting 22 mRNA programs and saving $500 million, yet few are catching the crucial details about his openly stated agenda to create a universal Covid and flu vaccine instead, or the coincidental nature of that amount of money being exactly the amount needed for the Stargate gene therapy program. Meanwhile, as we have seen recently with more genetically modified mosquitoes being dropped in Hawaii, the Chikungunya virus is supposedly spreading in China; and US media, while saying there is no threat, has blamed it on mosquitoes the same week that an active shooter roamed the streets near the CDC headquarters. The shooter took his vaccine and blamed it for why he got sick, creating a PR campaign backed by the pharmaceutical companies to call him an anti-vaxxer who had mental health issues. Something strange is brewing. *The is the FREE archive, which includes advertisements. If you want an ad-free experience, you can subscribe below underneath the show description.FREE ARCHIVE (w. ads)SUBSCRIPTION ARCHIVEX / TWITTER FACEBOOKWEBSITECashApp: $rdgable EMAIL: rdgable@yahoo.com / TSTRadio@protonmail.comBecome a supporter of this podcast: https://www.spreaker.com/podcast/the-secret-teachings--5328407/support.

In this special replay of one of our all-time most popular episodes, we dive deep into one of the most debated topics in the pharmaceutical industry: R vs SAS. Together with Thomas Neitmann and my co-host Sam Gardner, we compare these two powerful statistical programming tools from multiple angles — ease of learning, day-to-day usability, community support, visualization capabilities, regulatory acceptance, and more. Whether you are a seasoned SAS programmer, an R enthusiast, or someone deciding which tool to focus on, this conversation will give you valuable insights into where each shines, where they struggle, and how the industry is evolving.

President Donald Trump has been threatening tariffs on pharmaceuticals for months. This week, he told CNBC that he's planning to impose a “small tariff” on prescription drugs soon, which could eventually be raised to 250%. Today, we delve into what tariffs could mean for prescription drug imports and the patients who rely on them. Also: a temporary appointment at the Fed, tariffs on gold, and spending on soccer sponsorships in the Democratic Republic of Congo.

President Donald Trump has been threatening tariffs on pharmaceuticals for months. This week, he told CNBC that he's planning to impose a “small tariff” on prescription drugs soon, which could eventually be raised to 250%. Today, we delve into what tariffs could mean for prescription drug imports and the patients who rely on them. Also: a temporary appointment at the Fed, tariffs on gold, and spending on soccer sponsorships in the Democratic Republic of Congo.

President Trump has promised pharmaceutical tariffs. What would that mean for our healthcare supply chains...and the cost we pay as patients? Prashant Yadav, a healthcare supply chain expert at the Council on Foreign Relations, joins us.

* Would pharmaceutical tariffs be healthy or harmful for us? * Why are the mosquitoes so bad in Louisiana?

  President Donald Trump, along with other high tariffs, have said that pharma tariffs would start small but could balloon to nearly 250%  in an attempt to move drug manufacturing to the U.S. These tariffs could affect how patients afford their prescriptions and could threaten abilities to fund research into new medicines. International Trade Attorney Michelle Schulz has been monitoring these developments and goes into detail how this blunt attack on pharmaceuticals could be bad for everyone. 

What if one of the most advanced pharmaceutical manufacturing facilities in America was quietly being built in Sacramento? In this episode, Jay Shukla, founder and CEO of Nivagen Pharmaceuticals, shares the incredible story of how he went from a broke student with a borrowed plane ticket to leading a fast-growing pharma company reshoring production in the U.S. This is more than just a business success story — it's a deep dive into entrepreneurship, innovation, and the grit it takes to build something that actually matters.

Is your nervous system keeping you stuck in old patterns and narratives? Josh Trent welcomes Sarah Baldwin, Somatic Experiencing Practitioner, to the Wellness + Wisdom Podcast, episode 763, to reveal how we “time travel” through our autonomic nervous system, reacting to past experiences instead of living in the present, and how we can regulate our nervous system, heal generational wounds, and create deep, authentic connection by loving our parts into wholeness.

How do researchers keep our dirt clean? How can earthworms, duckweed, birds and bees help us ensure environmental safety? Find out now by listening in with our experts from Charles River's Hungarian site - Szabolcs Gáty and David Esdaile.

Liberated Life Series | Episode 762 Join Josh Trent, host of the Wellness + Wisdom Podcast, and Mar, co-host of the Liberated Life Series, as they expose why survival mode is the silent epidemic nobody's talking about, how it's keeping you anxious, reactive, and disconnected from your true power, and why you still feel stuck despite doing all the right things. This episode will reveal the shocking reason why! We ALL have problems. Stop hiding. Start living life liberated. Learn how to set yourself free from self-sabotage, limiting beliefs, thoughts, and behaviors so you will have lifelong confidence and clarity of purpose through a thriving community and practical tools, guiding you to play a new reality game. Join Josh and others in the Liberated Life Tribe to: Discover lifelong confidence, clarity, and a true sense of purpose with practical tools and a supportive community. Learn to rewrite your reality + master a new “reality game.” Unlock your highest potential in your physical, mental, emotional, spiritual + financial SELF beyond your wildest dreams through accessing the power of surrender to trust life + create new results. Join the Tribe Today (It's FREE) Listen To Episode 762 As Josh Trent Uncovers: [00:00] How the Survival Paradigm Hijacks Your Mind Why 95% of your thoughts are stuck in unconscious survival loops. How Dr. David Hawkins' frequency scale reveals the hidden trap of "good vibes only." Why mindset alone can't pull you out, your identity must evolve. What the Wellness Pentagon™ reveals about true multidimensional nourishment. Why being stuck isn't weakness, it's the voice of your inner victim feeding noise, not truth. [05:00] Becoming the Signal in a World Full of Noise How your environment programs your biology unless you intervene consciously. Why your body is a human battery and how to stop letting distractions drain you. What it means to be the signal above the noise (and why it's not about your nervous system). How the five elements of the Wellness Pentagon™ rewire your internal guidance system. [10:15] The Missing Link Between Knowing + Doing Why willpower alone will never get you unstuck. The real reason you can't meditate, journal, or change, even when you know it'll help. How pressure, time, curiosity, and love create the internal bridge to lasting transformation. Why transformation is a maturation process, not a breakthrough moment. [13:55] Fear Is a Liar: Choose Love How unconscious fear blocks you from becoming who you're here to be. The emotional cleanup Josh did to finally feel worthy of love. Why porn, addiction, and self-sabotage are symptoms, not root causes. [16:25] Life Won't Get Easier Why life will always throw challenges at you. How building your “human capacitor” increases your power to hold life's intensity. Why nourishing yourself in all five domains can change the collective. [19:10] The Real Reason You're Still Stuck Why emotional pain lingers longer than it should (hint: it's not the feeling, it's the belief). The forgotten sequence that governs your life: Belief → Thought → Feeling → Action. How unconscious stories like "I'm unworthy" and "I'm not lovable" trap you in survival mode. [22:55] How to Clear Generational Trauma + Societal Conditioning The 3 layers of emotional purification: intergenerational, societal, and internal. Why consuming content is not the same as embodying truth. How to finally live your truth instead of just speaking it. [25:45] Why Emotional Maturity Is the Key to Ending Pain The critical difference between exploring emotions and getting lost in them. Why grief is a lower vibration than acceptance (and how to rise above it). How to turn grief into growth and reconnect with God without bypassing pain. Leave Wellness + Wisdom a Review on Apple Podcasts

Tune in as Glenn Hunzinger, PwC's Health Industries Leader, sits down with Nicole Montgomery, Shannon O'Shea, and Phil Sclafani to unpack the sweeping implications of the newly signed One Big Beautiful Bill Act (OBBBA). With nearly a third of the bill dedicated to healthcare, the team explores how this landmark legislation will reshape coverage, funding, and delivery across the payer, provider, and pharma landscape.Discussion highlights:The OBBBA introduces new work requirements and eligibility rules that could lead to coverage loss for over 13 million people, placing new burdens on payers and statesProviders face increased uncompensated care, especially in rural areas, with added administrative complexity and a push toward technology and alternative care modelsPayers are bracing for membership loss, reduced Medicaid funding, and increased administrative load as new eligibility rules take effectPharma may see reduced demand from public programs but gains through an orphan drug exemption and incentives for domestic manufacturingThe bill's sweeping changes will disrupt healthcare, but with foresight, organizations can model financial impact, prepare for operational disruption, and plan strategic responsesSpeakers:Glenn Hunzinger (host), Health Industries Leader, PwCShannon O'Shea, Principal, Health Transformation, Provider Clinical Transformation, PwCPhil Scalfani, Principal, Customer Transformation, Pharmaceutical & Life Sciences, PwCNichole Montgomery, Principal, Health Transformation, Health Services, PwCLinked Materials:https://www.pwc.com/us/en/industries/health-industries/library/impact-of-obbba-on-us-health-system.html https://www.pwc.com/us/en/industries/health-industries/health-policy-and-intelligence-institute.htmlFor more information, please visit us at: https://www.pwc.com/us/en/industries/health-industries/health-research-institute/next-in-health-podcast.html.

In this episode, Tina talks with Faraz Khan about female hair loss. In particular, he shares how hormonal changes in perimenopause and menopause may contribute to this problem. Faraz talks about the complexities and offers insights and prevention strategies. Faraz discusses the following topics: - The complexities of hair loss in women - The causes of hair loss and prevention strategies - Treatment options to regrow hair - The importance of addressing underlying health issues - Five nutrients necessary for hair growth - Stress hair loss vs hormonal hair loss - Pharmaceutical and natural solutions for hair loss - And more… Connect with Tina Haupert: https://carrotsncake.com/ Facebook: Carrots 'N' Cake https://www.facebook.com/carrotsncake Instagram: carrotsncake https://www.instagram.com/carrotsncake YouTube: Tina Haupert https://www.youtube.com/user/carrotsncake Pinterest: Carrots 'N' Cake Hormone Testing & Nutrition Coaching https://www.pinterest.com/carrotsncake/ About Tina Haupert: Tina Haupert is the owner of Carrots ‘N' Cake as well as a Certified Nutrition Coach and Functional Diagnostic Nutrition Practitioner (FDN-P). Tina and her team use functional testing and a personalized approach to nutrition to help women find balance within their diets while achieving their body composition goals. Connect with Faraz Khan: https://fullyvital.com/ Instagram: https://www.instagram.com/fullyvitalhair/ Facebook: https://www.facebook.com/profile.php?id=100070405412613 Youtube: https://www.youtube.com/channel/UCT2G03nQ7wnDNxt9DLfWnUg About Faraz Khan: Faraz Khan is the founder of FullyVital and host of the Anti-Aging Hacks Podcast. A leading expert in the field of hair loss in women, he has dedicated his career to understanding the complex interplay of hormones, diet, and lifestyle on hair health. Faraz's work focuses on the molecular level of how testosterone and DHT affect hair follicles. His innovative thinking and empathetic approach have made him a sought-after voice in the field, helping countless individuals regain confidence and control over their hair health. Faraz's insights into hormonal imbalances, particularly around menopause, have contributed to a broader understanding of hair loss patterns in women. Whether through FullyVital's products or his engaging podcast, Faraz continues to educate and inspire, making a tangible difference in the lives of many.

Is your mouth silently sabotaging your overall health? And could your dentist be the missing link to true wellness? Josh Trent welcomes Dr. Dominik Nischwitz, Biological Dentist, to the Wellness + Wisdom Podcast, episode 760, to reveal why traditional dentistry focuses on repair while biological dentistry optimizes health, how metal fillings act as EMF antennas, and why clearing oral infections can reboot your gut microbiome and restore your vitality.

Discover the groundbreaking conversation between Wellness + Wisdom host Josh Trent and longevity expert Ian Clark as they reveal how to break free from inherited trauma and step into true vitality. In this eye‑opening episode of the Younger Than Yesterday Podcast, hosted by Ian Clark, Josh shares his personal transformation, from childhood stress imprints and addiction to becoming a father, guide, and creator of Emotional Epigenetics™. You'll learn how breathwork rewires your nervous system, why our biology often argues with our reality, and how somatic practices can release decades of stored trauma.

Summer is in full swing and that means while Dr. Karin and Pastor Elliott are out we are going back in time to Ep. 262 and replay one of our more popular episodes on mental health! We believe this topic is just as relevant today as it was back in 2023. Whether you're hearing this episode again or for the first time we hope it will empower you! We're in the midst of a mental health war. Over the last 50 years, we've raised awareness and developed abundant treatment options, yet Americans' rates of depression and anxiety continue to skyrocket (Whitaker, 2015).Today, Elliott and I discuss my reflections on his recent messages about the epidemics of anxiety, depression, loneliness, and addiction.We conceptualize the current mental health landscape as a war for two reasons:  (1) because so many Americans battle psychological concerns and (2) professionals are in the midst of deeply contentious disputes regarding how to best treat clients' emotional distress.Pharmaceutical corporations and many psychiatrists view this issue through a medical model i.e. patients are diagnosed with psychiatric illnesses and are prescribed pills to manage symptoms. But despite an exponential increase in the use of psychotropic medications, the number of Americans filing disability claims due to mental conditions has tripled over the last two decades (Whitaker, 2015).Elliott and I argue that a “medicalized” framework pathologizes reasonable responses to trauma and pain; this frameworks also disempowers clients—which is both an unintended and unfortunate consequence. Furthermore, and very importantly, most pharmaceutical interventions for psychological conditions simply don't work as promised—if at all (Brogan, 2016, 2019; Whitaker, 2015). Join our conversation to learn the necessary tactics for engaging in this mental health war! Works CitedBrogan, K. (2016). A mind of your own:  The truth about depression and how women can heal their bodies to reclaim their lives. Harper Wave.Brogan, K. (2019). Own yourself:  The surprising path beyond depression, anxiety, and fatigue to reclaiming your authenticity, vitality, and freedom. Hay House.Spielmans, G., Spence-Sing, T., & Parry, P. (2020). Duty to warn:  Antidepressant black box suicidality warning is empirically justified. Frontiers in Psychiatry, 20. ttps://www.frontiersin.org/articles/10.3389/fpsyt.2020.00018/fullWhitaker, R. (2015). Anatomy of an epidemic. Broadway Books.Dr. Karin & Pastor Elliott AndersonWebsite: http://loveandlifemedia.com/Empowered Dating Playbook: smarturl.it/EmpoweredDatingBookInstagram: @dr.karin | @pastorelliottanderson

Why can't you quit your bad habits, no matter how hard you try? And are you ready to uncover the crucial missing link? Josh Trent welcomes Dr. Jud Brewer, Neuroscientist and Psychiatrist, to the Wellness + Wisdom Podcast, episode 758, to reveal how your survival mechanisms hijack your mind, why willpower is NOT the key to quitting bad habits, and how understanding habit formation rewires your brain for lasting change.

Wellness + Wisdom: Liberated Life Series | Episode 757 Join Josh Trent, host of the Wellness + Wisdom Podcast, and Mar, co-host of the Liberated Life Series, as they expose why people pleasing and being nice are a fear-based survival response, how somatic recognition and body awareness can help you shift from people-pleaser to unapologetically you, and how your body shows you when you're being inauthentic. We ALL have problems. Stop hiding. Start living life liberated. Learn how to set yourself free from self-sabotage, limiting beliefs, thoughts, and behaviors so you will have lifelong confidence and clarity of purpose through a thriving community and practical tools, guiding you to play a new reality game. Join Josh and others in the Liberated Life Tribe to: Discover lifelong confidence, clarity, and a true sense of purpose with practical tools and a supportive community. Learn to rewrite your reality + master a new “reality game.” Unlock your highest potential in your physical, mental, emotional, spiritual + financial SELF beyond your wildest dreams through accessing the power of surrender to trust life + create new results. Join the Tribe Today (It's FREE)

In this episode of FYI, Chief Futurist, Brett Winton, and Analyst Nemo Marjanovic speak with Alex Zhavoronkov, founder and CEO of Insilico Medicine. Together, they explore the promise of artificial intelligence in transforming the drug discovery process—cutting years off timelines and dramatically reducing costs. Alex shares Insilico's journey from algorithm-first beginnings to a full-stack AI-driven biotech company, highlighting their unique “pan flute” model approach to drug development and the vision of building a “pharmaceutical superintelligence.” The discussion touches on Insilico's clinical progress, including a molecule that recently completed a Phase 2 trial, and how its generative platforms are helping to tackle complex diseases with a focus on longevity.Key Points From This Episode:00:00:00 AI's promise in streamlining the drug discovery process00:03:06 The economics of preclinical development and AI's role in optimization00:04:43 Potential cost and timeline reductions: $2.4B down to $600M, 13 years to 800:07:39 Comparing Insilico's approach to peers like Recursion and AbSci00:10:35 Literature-driven vs. biology-driven models in drug discovery00:13:07 Why a dominant AI platform could reshape biotech industry consolidation00:14:57 Why biologics may be more suited to AI than small molecules00:17:35 Alex Zhavoronkov on founding Insilico and his mission in longevity science00:21:00 From algorithms to real drugs: Insilico's transition to clinical development00:23:15 Managing the pace of AI progress vs. the slow cycle of experimental validation00:27:10 How “pharmaceutical superintelligence” enables prompt-to-drug workflows00:32:26 Validation, trust, and why Insilico runs on both old and frontier models00:39:22 The “pan flute” architecture: stacking specialized models with reinforcement learning00:42:36 Building and training a unified multimodal model for chemistry and biology00:45:32 Public data, clean pipelines, and Insilico's automated validation lab00:50:47 The business model behind Insilico: selling candidates and licensing platforms00:55:12 Why pharma buyers care more about data room quality than pricing01:00:25 On profitability, licensing success, and the dream of a self-sustaining AI biotech01:01:38 Longevity and the search for fundamental mechanisms of aging

View the Show Notes Page for This Episode Become a Member to Receive Exclusive Content Sign Up to Receive Peter's Weekly Newsletter In this episode from July 2022, Peter dives deep into the topic of bone health and explains why this is an important topic for everyone, from children to the elderly. He begins with an overview of bone mineral density, how it's measured, how it changes over the course of life, and the variability between sexes largely due to changes in estrogen levels. From there he provides insights into ways that one can improve bone health, from exercise to nutrition supplements to drugs. Additionally, Peter discusses what happens when one may be forced to be sedentary (e.g., bedrest) and how you can work to minimize the damage during these periods. While this original episode is an AMA, it is available in full to all listeners as a special rebroadcast. We discuss: Overview of bone health topics to be discussed [2:30]; Bones 101: bone function, structure, and more [6:15]; Bone mineral density (BMD), minerals in bone, role of osteoblasts and osteoclasts, and more [9:30]; The consequences of poor bone health [14:30]; The devastating nature of hip fractures: morbidity and mortality data [18:00]; Where fractures tend to occur in the body [23:45]; Defining osteopenia and osteoporosis [25:30]; Measuring BMD with DEXA and how to interpret scores [28:00]; Variability in BMD between sexes [35:15]; When should people have their first bone mineral density scan? [37:45]; How BMD changes throughout the life and how it differs between men and women [40:15]; How changes in estrogen levels (e.g., menopause) impact bone health [45:15]; Why HRT is not considered a standard of care for postmenopausal bone loss [49:00]; Factors determining who may be at higher risk of poor bone health [52:00]; Common drugs that can negatively impact BMD [55:45]; How children can optimize bone health and lay the foundation for the future [59:30]; Types of physical activity that can positively impact bone health [1:03:30]; How weight loss can negatively impact bone health and how exercise can counteract those effects [1:12:15]; Nutrition and supplements for bone health [1:16:00]; Pharmaceutical drugs prescribed for those with low BMD [1:18:45]; Impact of extreme sedentary periods (e.g., bedrest) and how to minimize their damage to bone [1:23:30]; and More. Connect With Peter on Twitter, Instagram, Facebook and YouTube

Ozempic is one of the most import new medications in a generation. The scientist who created it is a self-described "nerd," who grew up on a farm in Denmark and has no interest in the limelight. Lotte Knudsen started her career working on laundry detergent enzymes, but eventually joined a team at the Danish pharmaceutical company Novo Nordisk that was tasked with looking for new treatments for diabetes. She was convinced that a recently discovered human hormone called GLP-1 could be made into a powerful medication, not only for Type 2 diabetes, but also for weight loss. It took 20 years of hard work and persistence for her and her team to figure it out, but their creation now shows promise as a worthy foe of heart disease, kidney disease, Parkinson's, alcoholism & Alzheimer's as well. In this episode Lotte Knudsen tells her story, and we hear from two of the other scientists who made critical contributions to this revolution in medicine: Mads Thomsen and Daniel Drucker.